Ceapro Inc V.CZO

Interesting Chart Pattern Shows.......

[oats]

An interesting chart pattern below.  

It suggests that we are either at resitance or poised for a breakout to test the recent highs.  I will favor the latter.

Stockwatch Chart for C : CZO

[Ciao]

The share price rose sharply in mid August after the McMaser Covid research update and Q2, it then over corrected to low 60's (wiping out gains from these 2 great fundamental catalysts), has consolidated between 60 - 70 and has just broken out of the trading range this week. The catalyst is the use of increased NRC grant towards the large scale industrial mfg of PGX Y-BG at the PGX demo plant

[prophetoffacts]

This post has been removed in accordance with Community Policy

[Ciao]

What surprises me as well are those involved directly in the research, those that work at Ceapro, I don't know if they are actively buying or recommending this company to their social circle for investment consideration.  You know what Peter Lynch had said about looking for investment ideas.

[prophetoffacts]

This post has been removed in accordance with Community Policy

[westcoast1000]

While I appreciate these posts and the important points they convey, I remain very sceptical that the company has enough senior management with relevant experience to come even close to achieving what is called for in the recent notes. Look at the list from Oats of what is expected this fall. Who is managing all these projects? Who of any of those folks has any experience about clinical trials

[prophetoffacts]

This post has been removed in accordance with Community Policy

[oats]

westcoast, Read the Noble Capital Partners updated research report. They seem to be relatively impressed with Gilles Gagnon's credentials.

[westcoast1000]

Oats and prophet, Thanks for your replies. I did read again the Noble Capital report and they do have a couple of positive sentences on Gilles' credentials. I realize he has clinical trials experience and worked in big pharma. My point is that Gilles cannot do everthing and the list of diverse project in diverse potential markets with diverse partners is long. So, while recognizing Gilles

[westcoast1000]

Follow up to the previous message, I make these comments as someone who has over 150 K shares in this company. I am not a basher by any means. I am there with all the shareholders and the employees who want the company to succeed. I also do not see a board that is willing to tell the CEO to do things differently, or put resources into making the organization stronger. So we wait and wonder if

[Ciao]

WC, You are doing the right thing, looking for the weakest link in this story, trying to really understand the company. As per depth in the company, I would agree, they should look at succession planning sometime down the road as there is no one likely able to steer the ship besides Gilles. As for resoucres, they did some restructuring earlier in the year and are getting help as needed

[Stinzo]

Thanks westcoast for your posts. I can definitely relate.  I hope the next 30 days will be fruitful.  Best,

[prophetoffacts]

This post has been removed in accordance with Community Policy

[prophetoffacts]

This post has been removed in accordance with Community Policy

[Ciao]

Oats, Your point # 4) Beta glucan pill trial was to commenced enrollment this month I believe you mean complete enrollment as trials are already underway, they needed to complete enrollment to accomodate their request to modify the study to allow participants that only wanted to take the BG pill as a stand alone treatment I'm somewhat excited by the talk of starting human clinical studies